What is hypoxia-inducible factor-1 doing in the allergic lung?

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 7, 2011, Pages 815-817

  Rangasamy, T ^a   Semenza, G L ^b   Georas, S N ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MUCIN 5AC; OVALBUMIN; OXYGEN; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ASTHMA; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL SURVIVAL; DNA SEQUENCE; GENE DELETION; GENE EXPRESSION; HUMAN; HYDROXYLATION; HYPOXIA; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOID ORGAN; MACROPHAGE ACTIVATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; RESPIRATORY TRACT INFLAMMATION; REVIEW; TH2 CELL;

ALLERGENS; ANIMALS; ASTHMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LUNG; MICE; RESPIRATORY HYPERSENSITIVITY; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 79958115127     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02593.x     Document Type: Review

References (23)

1. Semenza GL,. Life with oxygen. Science 2007; 318: 62-64. (Pubitemid 47538005)
2. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al., The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275. (Pubitemid 29246458)
3. Ivan M, Kondo K, Yang H, et al., HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292: 464-468. (Pubitemid 32335941)
4. Wang GL, Jiang BH, Rue EA, Semenza GL,. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-5514.
5. Semenza GL,. Oxygen homeostasis. Wiley Isntesrdiscip Rev Syst Biol Med 2010; 2: 336-361.
6. Nizet V, Johnson RS,. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 2009; 9: 609-617.
7. Takeda N, O'Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, et al., Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev 2010; 24: 491-501.
8. Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG, et al., Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 2001; 167: 6140-6149. (Pubitemid 33081540)
9. Roman J, Rangasamy T, Guo J, Sugunan S, Meednu N, Packirisamy G, et al., T-cell activation under hypoxic conditions enhances IFN-gamma secretion. Am J Respir Cell Mol Biol 2009; 42: 123-128.
10. Huerta-Yepez S, Baay-Guzman GJ, Bebenek IG, Hernandez-Pando R, Vega MI, Chi L, et al., Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis. Allergy 2011;in press.
11. Lee YC, Lee HK,. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol 2001; 107: 1106.
12. Detoraki A, Granata F, Staibano S, Rossi FW, Marone G, Genovese A,. Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy 2010; 65: 946-958.
13. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al., Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 2004; 10: 1095-1103. (Pubitemid 39424871)
14. Kim YS, Choi SJ, Tae YM, Lee BJ, Jeon SG, Oh SY, et al., Distinct roles of vascular endothelial growth factor receptor-1- and receptor-2-mediated signaling in T cell priming and Th17 polarization to lipopolysaccharide- containing allergens in the lung. J Immunol 2010; 185: 5648-5655.
15. Fajardo I, Svensson L, Bucht A, Pejler G,. Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. Am J Respir Crit Care Med 2004; 170: 477-484. (Pubitemid 39209127)
16. Hoshino M, Fujita Y, Saji J, Inoue T, Nakagawa T, Miyazawa T,. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma. Allergy 2005; 60: 1394-1400. (Pubitemid 41476182)
17. McIntosh BE, Hogenesch JB, Bradfield CA,. Mammalian Per-Arnt-Sim proteins in environmental adaptation. Annu Rev Physiol 2010; 72: 625-645.
18. Guo J, Lu W, Shimoda LA, Semenza GL, Georas SN,. Enhanced interferon-gamma gene expression in T Cells and reduced ovalbumin-dependent lung eosinophilia in hypoxia-inducible factor-1-alpha-deficient mice. Int Arch Allergy Immunol 2009; 149: 98-102.
19. Cramer T, Yamanishi Y, Clausen BE, Förster I, Pawlinski R, Mackman N, et al., HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003; 112: 645-657. (Pubitemid 36331777)
20. Colgan SP, Taylor CT,. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 2010; 7: 281-287.
21. Feinman R, Deitch EA, Watkins AC, Abungu B, Colorado I, Kannan KB, et al., HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2010; 299: G833-G843.
22. Kojima H, Gu H, Nomura S, Caldwell CC, Kobata T, Carmeliet P, et al., Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha -deficient chimeric mice. Proc Natl Acad Sci USA 2002; 99: 2170-2174. (Pubitemid 34169033)
23. Semenza GL,. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 2010;in press.